GSK (GSK) announced that new drug applications have been accepted for review by the China National Medical Products Administration and ...

Zhaoke Ophthalmology Limited is responsible for developing and obtaining regulatory approval for NVK-002 in Greater China, ...

President Donald Trump’s executive order imposing a 10% tariff on Chinese imports is likely to drive up the cost of generic ...

Wen Shuhao helped speed up the development of Pfizer’s Covid oral drug, Paxlovid. Now the chairman of Xtalpi wants to help ...

There is growing enthusiasm about China’s potential to speed up drug development with AI. And companies outside the country ...

today announced that new drug applications have been accepted for review by the China National Medical Products Administration and submitted to the Japanese Ministry of Health, Labour and Welfare for ...

The U.S. Food and Drug Administration has approved Supernus Pharmaceuticals' drug-device combination to treat movement-related symptoms of Parkinson's disease, the drugmaker said on Tuesday.

Licensing deals struck by Chinese biotech ... are conducted and applications are submitted to regulators for marketing approval. Out-licensing typically involves a drug discoverer and patent ...

has reviewed the Company’s Investigational New Drug (IND) application and it is in effect. This is a critical step toward the initiation of the Phase 1 clinical trial for OCU500—an inhaled ...

Adding camrelizumab and rivoceranib to TACE improved PFS in patients with unresectable HCC in a phase 2 trial.